Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease

ClinicalTrials.gov ID: NCT07355296

Public ClinicalTrials.gov record NCT07355296. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 9, 2026, 1:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

PODOMOUNT-Basket, a Phase II, Multicentre, Randomised, 2-arm Parallel-group, Double-blind, Placebo-controlled Basket Trial to Assess Safety, Tolerability, PK, and Efficacy of BI 764198 in Four Proteinuric Kidney Diseases

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is open to adults with certain kidney conditions, including secondary focal segmental glomerulosclerosis (sFSGS), treatment-resistant primary minimal change disease (TR-pMCD), Alport Syndrome (AS), and treatment-resistant primary membranous nephropathy (TR-pMN). Adolescents with treatment-resistant primary MCD can also participate in this study. The purpose of this study is to find out whether a medicine called BI 764198 helps people with these kidney conditions. Participants are put into 2 groups randomly, which means by chance. One group takes BI 764198 tablets, and the other group takes placebo tablets. Placebo tablets look like BI 764198 tablets but do not contain any medicine. Participants take a tablet once a day for 20 weeks. All participants also continue their standard medication for their kidney condition during the study. Participants have twice the chance of being placed in the BI 764198 group than in the placebo group. Participants are in the study for about 7 months. During this time, they visit the study site 6 times and have 3 phone calls. Doctors regularly test the protein levels in participants' urine by collecting urine samples. They also check kidney function by taking blood samples. The results are compared between the two groups to see whether the treatment works. The doctors also regularly check participants' health and take note of any unwanted effects.

Study identification

NCT ID
NCT07355296
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
132 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 22, 2026
Primary completion
Jan 19, 2028
Completion
Feb 16, 2028
Last update posted
Sep 1, 2026

2026 – 2028

United States locations

U.S. sites
26
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
Nephrology Consultants, LLC Huntsville Alabama 35805 Recruiting
Kidney Disease Medical Group Glendale California 91206 Recruiting
Amicis Research Center - Balboa Granada Hills California 91344 Recruiting
Academic Medical Research Institute - Glendale Los Angeles California 90022 Recruiting
University of California Los Angeles Los Angeles California 90095 Not yet recruiting
Colorado Kidney Care Denver Colorado 80220 Recruiting
Florida Kidney Physicians - Boca Raton Boca Raton Florida 33487 Recruiting
Florida Kidney Physicians, LLC - Fort Lauderdale Fort Lauderdale Florida 33316 Recruiting
Total Research Group, LLC Miami Florida 33126 Recruiting
CTR Oakwater, LLC Orlando Florida 32806 Recruiting
Florida Kidney Physicians - Riverview/Brandon Riverview Florida 33578 Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 Not yet recruiting
Endeavor Health Evanston Illinois 60201 Not yet recruiting
Johns Hopkins Hospital Baltimore Maryland 21287 Not yet recruiting
St. Clair Nephrology Research, LLC - Shelby Township Shelby Michigan 48315 Recruiting
New York Nephrology and Dialysis Access Surgery, PC Clifton Park New York 12065 Recruiting
Queens Long Island Kidney Center Fresh Meadows New York 11366 Not yet recruiting
NYU Langone Nephrology Associates-Mineola Mineola New York 11501 Recruiting
Duke University Medical Center Durham North Carolina 27710 Not yet recruiting
Cleveland Clinic Cleveland Ohio 44195 Not yet recruiting
Nationwide Children's Hospital Columbus Ohio 43205 Not yet recruiting
Northeast Clinical Research Center Bethlehem Pennsylvania 18017 Not yet recruiting
Southeast Renal Research Institute Chattanooga Tennessee 37404 Recruiting
Nephrotex Research Group Dallas Texas 75231 Not yet recruiting
Provecta Researh Network Houston Texas 77027 Recruiting
West Virginia University Medicine Morgantown West Virginia 26506 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 137 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07355296, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 1, 2026 · Synced Sep 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07355296 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →